PPARG and obesity due to melanocortin 4 receptor deficiency: Proposals to target EZH2–HDAC9c interaction for the treatment of age-associated osteoporosis and obesity are supported by the report that HDAC9c attenuates adipogenesis by interfering with PPARγ transcriptional activity [163].